Latest Information Update: 28 Sep 2016
At a glance
- Originator 3SBio
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preregistration Breast cancer; Gastric cancer
Most Recent Events
- 22 Sep 2016 Preregistration for Breast cancer (Metastatic disease, Late-stage disease, Second-line therapy or greater) in China (Parenteral) before September 2016 (3SBio pipeline, September 2016)
- 22 Sep 2016 Preregistration for Gastric cancer (Metastatic disease, Late-stage disease) in China (Parenteral) before September 2016 (3SBio pipeline, September 2016)